Look behind the lecture: should age be accounted for in HTA decision-making?

Written by VIVIAN RECKERS-DROOG (ERASMUS SCHOOL OF HEALTH POLICY AND MANAGEMENT)

Age societal preferences in HTA

In this feature, following participating in an Issue Panel at the International Society for Pharmacoeconomics and Outcomes Research’s 2021 virtual annual meeting (Virtual ISPOR 2021; 17–20 May), Vivian Reckers-Droog (Erasmus School of Health Policy and Management, Rotterdam, The Netherlands) presents an overview of the controversy surrounding accounting for age-related societal preferences in health technology assessment (HTA) decision-making. Please could you introduce yourself, your organization(s) and provide a brief summary of your career to date? My name is Vivian Reckers-Droog and I am an Assistant Professor of Equity Considerations within the Department of Health Economics at the Erasmus School of Health...

To view this content, please register now for access

It's completely free